Department of Neuroscience and Cell Biology, Rutgers Robert Wood Johnson Medical School, Piscataway, NJ, 08854, USA.
J Neuroinflammation. 2019 Jan 17;16(1):11. doi: 10.1186/s12974-018-1390-3.
Microglia, the resident immune cells of the brain, exhibit various morphologies that correlate with their functions under physiological and pathological conditions. In conditions such as aging and stress, microglia priming occurs, which leads to altered morphology and lower threshold for activation upon further insult. However, the molecular mechanisms that lead to microglia priming are unclear.
To understand the role of Par1b/MARK2 in microglia, we first expressed shRNA targeting luciferase or Par1b/MARK2 in primary microglial cells and imaged the cells using fluorescent microscopy to analyze for morphological changes. A phagocytosis assay was then used to assess functional changes. We then moved in vivo and used a Par1b/MARK2 knockout mouse model to assess for changes in microglia density, morphology, and phagocytosis using immunohistochemistry, confocal imaging, and 3D image reconstruction. Next, we used two-photon in vivo imaging in live Par1b/MARK2 deficient mice to examine microglia dynamics. In addition, a controlled-cortical impact injury was performed on wild-type and Par1b/MARK2-deficient mice and microglial response was determined by confocal imaging. Finally, to help rule out non-cell autonomous effects, we analyzed apoptosis by confocal imaging, cytokine levels by multiplex ELISA, and blood-brain barrier permeability using Evans Blue assay.
Here, we show that loss of the cell polarity protein Par1b/MARK2 facilitates the activation of primary microglia in culture. We next found that microglia in Par1b/MARK2 deficient mice show increased density and a hypertrophic morphology. These morphological changes are accompanied with alterations in microglia functional responses including increased phagocytosis of neuronal particles early in development and decreased surveillance of the brain parenchyma, all reminiscent of a primed phenotype. Consistent with this, we found that microglia in Par1b/MARK2 deficient mice have a significantly lower threshold for activation upon injury.
Together, our studies show that loss of Par1b/MARK2 switches microglia from a surveillant to a primed state during development, resulting in an increased neuroinflammatory response to insults.
小胶质细胞是大脑的固有免疫细胞,在生理和病理条件下表现出不同的形态,这些形态与它们的功能相关。在衰老和应激等情况下,小胶质细胞会发生启动,这导致其形态发生改变,并且在受到进一步损伤时激活的阈值降低。然而,导致小胶质细胞启动的分子机制尚不清楚。
为了了解 Par1b/MARK2 在小胶质细胞中的作用,我们首先在原代小胶质细胞中表达靶向荧光素酶或 Par1b/MARK2 的 shRNA,并使用荧光显微镜对细胞进行成像,以分析形态变化。然后进行吞噬作用测定,以评估功能变化。我们随后在体内进行操作,使用 Par1b/MARK2 敲除小鼠模型,使用免疫组织化学、共聚焦成像和 3D 图像重建来评估小胶质细胞密度、形态和吞噬作用的变化。接下来,我们使用活体 Par1b/MARK2 缺陷小鼠的双光子体内成像来检查小胶质细胞动力学。此外,在野生型和 Par1b/MARK2 缺陷型小鼠上进行控制性皮质撞击损伤,并通过共聚焦成像确定小胶质细胞的反应。最后,为了帮助排除非细胞自主效应,我们通过共聚焦成像分析细胞凋亡、通过多重 ELISA 分析细胞因子水平以及通过 Evans Blue 测定评估血脑屏障通透性。
在这里,我们表明,细胞极性蛋白 Par1b/MARK2 的缺失促进了原代小胶质细胞在培养中的激活。我们随后发现,Par1b/MARK2 缺陷型小鼠中的小胶质细胞密度增加,形态呈肥大状。这些形态变化伴随着小胶质细胞功能反应的改变,包括在发育早期对神经元颗粒的吞噬作用增加和对脑实质的监视减少,这与启动表型相似。与此一致的是,我们发现 Par1b/MARK2 缺陷型小鼠中的小胶质细胞在受伤时的激活阈值显著降低。
总之,我们的研究表明,Par1b/MARK2 的缺失使小胶质细胞在发育过程中从监视状态转变为启动状态,导致对损伤的神经炎症反应增加。